Amy Tiersten, MD

Conference Coverage

Front-Line Anastrozole, Palbociclib, Trastuzumab, and Pertuzumab for HR-Positive, HER2-Positive Metastatic Breast Cancer

12/19/2023

Amy Tiersten , MD;

Amy Tiersten, MD, Mount Sinai, discussed results from the phase 1/2 ASPIRE study investigating combination anastrozole, palbociclib, trastuzumab, and pertuzumab for previously untreated patients with HR-positive, HER2-positive metastatic...

Amy Tiersten, MD, Mount Sinai,...

12/19/2023

Oncology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 13 ⁠–⁠ November 16

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

See Full Calendar

Amy Tiersten, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products